Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Amedisys Inc (AMED)
Amedisys Inc (AMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,014,963
  • Shares Outstanding, K 32,559
  • Annual Sales, $ 2,223 M
  • Annual Income, $ 118,610 K
  • 60-Month Beta 1.01
  • Price/Sales 1.35
  • Price/Cash Flow 12.66
  • Price/Book 2.64
Trade AMED with:

Options Overview Details

View History
  • Implied Volatility 19.50% ( -1.05%)
  • Historical Volatility 53.66%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 63.31% on 10/14/22
  • IV Low 19.50% on 06/08/23
  • Put/Call Vol Ratio 4.18
  • Today's Volume 88
  • Volume Avg (30-Day) 331
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 6,789
  • Open Int (30-Day) 2,214

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 1.08
  • Number of Estimates 9
  • High Estimate 1.15
  • Low Estimate 0.97
  • Prior Year 1.47
  • Growth Rate Est. (year over year) -26.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.10 +26.54%
on 05/11/23
93.46 -1.03%
on 06/07/23
+12.16 (+15.14%)
since 05/08/23
3-Month
69.36 +33.35%
on 03/23/23
93.46 -1.03%
on 06/07/23
+7.67 (+9.04%)
since 03/08/23
52-Week
69.36 +33.35%
on 03/23/23
131.32 -29.56%
on 07/22/22
-23.11 (-19.99%)
since 06/08/22

Most Recent Stories

More News
Epam, C.H. Robinson fall; Palo Alto Networks, Circor rise

Stocks that traded heavily or had substantial price changes Monday: Epam, C

CIR : 47.71 (+0.10%)
AMED : 92.50 (-0.11%)
EPAM : 213.86 (+1.78%)
F : 13.55 (-0.29%)
CHRW : 91.36 (-0.59%)
PANW : 222.57 (+2.92%)
Why Shares of Amedisys Are Jumping Monday

The home healthcare company received a buyout offer from a segment of UnitedHealth Group.

UNH : 490.23 (+1.68%)
AMED : 92.50 (-0.11%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMAN, ARNC, AMED

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

EMAN : 2.00 (unch)
ARNC : 29.00 (-0.03%)
AMED : 92.50 (-0.11%)
AMEDISYS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. - AMED

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Amedisys, Inc. (NasdaqGS: AMED) to Option Care...

AMED : 92.50 (-0.11%)
OPCH : 31.43 (+2.11%)
ALERT: Rowley Law PLLC is Investigating Proposed Merger of Amedisys, Inc.

/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Amedisys, Inc. (NASDAQ: AMED) and its board of directors concerning the...

AMED : 92.50 (-0.11%)
OPCH : 31.43 (+2.11%)
Amedisys (AMED) Q1 Earnings Beat Estimates, Margins Dip

Amedisys (AMED) sees a year-over-year decline in the Hospice segment's revenues.

AMED : 92.50 (-0.11%)
JNJ : 159.52 (+0.63%)
ISRG : 309.63 (+0.78%)
EW : 83.85 (+0.44%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RUTH, MGTA, OPCH, AMED

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RUTH : 21.48 (+0.05%)
MGTA : 0.7163 (+0.89%)
OPCH : 31.43 (+2.11%)
AMED : 92.50 (-0.11%)
Shareholder Alert: Ademi LLP investigates whether Amedisys, Inc. has obtained a Fair Price in its transaction with Option Care Health

/PRNewswire/ -- Ademi LLP is investigating Amedisys (NASDAQ: AMED) for possible breaches of fiduciary duty and other violations of law in its transaction with...

AMED : 92.50 (-0.11%)
Amedisys (AMED) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to...

AMED : 92.50 (-0.11%)
AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amedisys, Inc. (NASDAQ: AMED) to Option Care Health, Inc. for 3.0213 shares of Option Care common stock for each share...

AMED : 92.50 (-0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure,...

See More

Key Turning Points

3rd Resistance Point 95.79
2nd Resistance Point 94.63
1st Resistance Point 93.61
Last Price 92.50
1st Support Level 91.43
2nd Support Level 90.27
3rd Support Level 89.25

See More

52-Week High 131.32
Fibonacci 61.8% 107.65
Fibonacci 50% 100.34
Fibonacci 38.2% 93.03
Last Price 92.50
52-Week Low 69.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar